In SCLC and other high-grade tumors, this function is so tightly regulated and essential that selective targeting can produce profound synthetic lethality—particularly when paired with dietary asparagine restriction or pharmacological L-asparaginase administration [57,58,59]. Here, ASPG is linked to small cell lung carcinoma.